Tag - genome

Rewiring Precision Medicine: How AI Is Transforming Science and Business

23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

Largest ever DNA sequencing dataset on UK child development studies available

Dense SNP-based analyses complement forensic anthropology biogeographical ancestry assessments

‘All of Us’ Research Program Identifies 275 Million New Genetic Variants

2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….

A Complete Y chromosome Sequence – Represents over 180,000 Years of Evolution of the Human Y Sequence

Changing the Clinical Genetic Testing Paradigm to Increase Sensitivity and Specificity

The Role of the Human Gut Microbiome in Alzheimer’s Disease Development

Broad Institute Launches $1K Sample-to-Report Clinical Whole-Genome Sequencing Service

The Cheap Genome Is Not Enough – We Need an “Accurate and Good Genome”

We Invite you to join enlightenbio’s Subject Matter Expert Network!

2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress

Copyright © 2026. enlighenbio LLC. All rights reserved.